378 results on '"Sanders, Jan-Stephan F."'
Search Results
2. Prognostic value of single photon emission computed tomography myocardial perfusion imaging for the prediction of MACE in pre- kidney transplant recipients: A systematic review and meta-analysis
3. The role of neutrophil extracellular trap formation in kidney transplantation: Implications from donors to the recipient
4. Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients
5. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study
6. Central Body Fat Distribution and Kidney Function after Living Kidney Donation
7. Systemic oxidative stress may be associated with reduced IgG antibody titers against SARS-CoV-2 in vaccinated kidney transplant recipients: A post-hoc analysis of the RECOVAC-IR observational study
8. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis
9. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis
10. The differential impact of early graft dysfunction in kidney donation after brain death and after circulatory death: Insights from the Dutch National Transplant Registry
11. The impact of pre-transplantation nephrectomy on quality of life in patients with autosomal dominant polycystic kidney disease
12. Comparison of 2 Immunosuppression Minimization Strategies in Kidney Transplantation: The ALLEGRO Trial
13. Considerable Variability Among Transplant Nephrologists in Judging Deceased Donor Kidney Offers
14. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study
15. Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Study
16. Comparison of 2 Immunosuppression Minimization Strategies in Kidney Transplantation: The ALLEGRO Trial
17. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial
18. CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis
19. Plasma Lead Concentration and Risk of Late Kidney Allograft Failure: Findings From the TransplantLines Biobank and Cohort Studies
20. Pre-donation assessment of cystatin C to improve prediction of pre- and post-donation GFR in potential living kidney donors.
21. #2681 Impact of sharing anti-SARS-CoV-2 antibody levels with Kidney Transplant Recipients on adherence to preventive measures and incidence of COVID-19
22. #1216 Comparable outcomes for old, older and very old deceased donors in old kidney transplant recipients
23. Corrigendum to “Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA–Associated Vasculitis.” Kidney Int. 2024;105(3):447–449
24. Corrigendum to “KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis.” Kidney Int. 2024;105(3S):S71–S116
25. The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment
26. Kidney Transplantation Improves Health-Related Quality of Life in Older Recipients
27. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
28. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
29. Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients
30. The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment
31. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study
32. Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients
33. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease:A nested case-control study
34. Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant Recipients
35. High-Density Lipoprotein Particles and Torque Teno Virus in Stable Outpatient Kidney Transplant Recipients
36. The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
37. Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis
38. Azathioprine Hypersensitivity Syndrome in a Cohort of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Patients
39. Corrigendum to “KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)–Associated Vasculitis.” Kidney International2024;105(3S):S71–S116
40. Smoking, Alcohol Intake and Torque Teno Virus in Stable Kidney Transplant Recipients
41. The Time-Dependent Association of Torque Teno Virus Load with the Level of SARS-CoV-2 S1 IgG Antibodies Following COVID-19 Vaccination in Kidney Transplant Recipients
42. Association of obesity with 3-month mortality in kidney failure patients with COVID-19
43. Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Study
44. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study
45. External ureteric stent versus internal double J stent in kidney transplantation: a retrospective analysis on the incidence of urological complications and urinary tract infections
46. Carboxypeptidase B2 gene polymorphisms in the donor associate with kidney allograft loss.
47. Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients:Results From the TransplantLines Biobank and Cohort Study
48. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands:a nationwide questionnaire study
49. Considerable Variability Among Transplant Nephrologists in Judging Deceased Donor Kidney Offers
50. Effect of Intravenous Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx): rationale and study protocol for a double-blind, randomised, placebo-controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.